Volume 19, Number 11—November 2013
Dispatch
Hantavirus Pulmonary Syndrome Outbreak, Brazil, December 2009–January 2010
Table 1
Characteristic | No. (%) male | No. (%) female | No. (%) total | |
---|---|---|---|---|
Age, y | ||||
<5 | 2 (22.2) | – | 2 (11.1) | |
5–10 | 3 (33.3 | 3 (33.3) | 6 (33.3) | |
11–15 | 3 (33.3) | 3 (33.3) | 6 (33.3) | |
16– 20 | 1 (11.1) | – | 1 (5.6) | |
>20 | – | 3 (33.3) | 3 (16.7) | |
Criterion of confirmation | ||||
Laboratorial | 9 (100.0) | 8 (88.9) | 17 (94.4) | |
Clinical and epidemiologic | – | 1 (11.1) | 1 (5.6) | |
Hospitalization | ||||
Hospital stay | 3 (33.3) | 3 (33.3) | 6 (33.3) | |
Observations at house I | 2 (22.2) | 3 (33.3) | 5 (27.8) | |
Never left Indian settlement | 4 (44.4) | 3 (33.3) | 7 (38.9) | |
Evolution | ||||
Cure | 9 (100.0) | 8 (88.9) | 17 (94.4) | |
Death | – | 1 (11.1) | 1 (5.6) | |
Total | 9 (50.0) | 9 (50.0) | 18 (100.0) |
*HPS, hantavirus pulmonary syndrome; –, none. Source: Health State Secretary of Mato Grosso, 2011.
Page created: September 12, 2013
Page updated: October 29, 2013
Page reviewed: October 29, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.